{"date":"2026-04-15","count":20,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4745-2026-04-15-1927-1u5n0ph","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-04-15","time":"19:27:28","subject":"代重要子公司合富（中國）醫療科技股份有限公司公告召開2025年年度股東大會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-04-15 19:27，「代重要子公司合富（中國）醫療科技股份有限公司公告召開2025年年度股東大會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4148-2026-04-15-1919-qcjwao","company_id":"4148","company":"全宇生技-KY","market":"上市","industry":"生技醫療","date":"2026-04-15","time":"19:19:47","subject":"代子公司PT All Cosmos Indonesia公告董事變動達三分之一","clause":"第6款","fact_date":"2026-04-15","cite_as":"公開資訊觀測站重大訊息：全宇生技-KY（4148），2026-04-15 19:19，「代子公司PT All Cosmos Indonesia公告董事變動達三分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6808-2026-04-15-1908-3sk6rx","company_id":"6808","company":"三鼎生技","market":"興櫃","industry":"生技醫療","date":"2026-04-15","time":"19:08:57","subject":"公告本公司「CALCIUM PHOSPHATE-BASED CORE-SHELLSTRUCTURED MATERIAL, METHOD FOR PREPARING THE SAME, ANDORAL CARE COMPOSITION USING THE SAME」取得美國發明專利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：三鼎生技（6808），2026-04-15 19:08，「公告本公司「CALCIUM PHOSPHATE-BASED CORE-SHELLSTRUCTURED MATERIAL,」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-04-15-1842-1cmcj0k","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-04-15","time":"18:42:18","subject":"公告本公司115年3月份自結應收帳款餘額及回收情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-04-15 18:42，「公告本公司115年3月份自結應收帳款餘額及回收情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4747-2026-04-15-1836-qzwwqw","company_id":"4747","company":"強生*","market":"上櫃","industry":"生技醫療","date":"2026-04-15","time":"18:36:11","subject":"公告本公司115年第1季自結合併損益","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：強生*（4747），2026-04-15 18:36，「公告本公司115年第1季自結合併損益」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1786-2026-04-15-1722-3ybca1","company_id":"1786","company":"科妍","market":"上市","industry":"生技醫療","date":"2026-04-15","time":"17:22:28","subject":"公告本公司「製造包含特安皮質醇之交聯透明質酸凝膠之方法及交聯透明質酸凝膠」取得中華民國經濟部智慧財產局專利核准審定書","clause":"第51款","fact_date":"2026-04-15","cite_as":"公開資訊觀測站重大訊息：科妍（1786），2026-04-15 17:22，「公告本公司「製造包含特安皮質醇之交聯透明質酸凝膠之方法及交聯透明質酸凝膠」取得中華民國經濟部智慧財產局專利核准審定書」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6617-2026-04-15-1710-17wsaxm","company_id":"6617","company":"共信-KY","market":"上櫃","industry":"生技醫療","date":"2026-04-15","time":"17:10:59","subject":"更正民國115年4月10日本公司買回庫藏股執行完畢內容(更正實際買回期間)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：共信-KY（6617），2026-04-15 17:10，「更正民國115年4月10日本公司買回庫藏股執行完畢內容(更正實際買回期間)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6847-2026-04-15-1656-1yomdib","company_id":"6847","company":"普瑞博","market":"興櫃","industry":"生技醫療","date":"2026-04-15","time":"16:56:26","subject":"(補充公告)公告本公司經主管機關核准撤銷114年現金增資發行新股案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普瑞博（6847），2026-04-15 16:56，「(補充公告)公告本公司經主管機關核准撤銷114年現金增資發行新股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4164-2026-04-15-1631-dtf31z","company_id":"4164","company":"承業醫","market":"上市","industry":"生技醫療","date":"2026-04-15","time":"16:31:51","subject":"本公司於2026/04/16召開法人說明會之相關資訊","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：承業醫（4164），2026-04-15 16:31，「本公司於2026/04/16召開法人說明會之相關資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2026-04-15-1551-u2kpc9","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2026-04-15","time":"15:51:50","subject":"公告本公司董事會補行委任薪資報酬暨提名委員會委員","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2026-04-15 15:51，「公告本公司董事會補行委任薪資報酬暨提名委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2026-04-15-1551-5rax5d","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2026-04-15","time":"15:51:11","subject":"公告本公司董事會決議員工認股權憑證轉換普通股增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2026-04-15 15:51，「公告本公司董事會決議員工認股權憑證轉換普通股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2026-04-15-1549-9h0ctm","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2026-04-15","time":"15:49:41","subject":"公告本公司董事會通過115年第一季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2026-04-15 15:49，「公告本公司董事會通過115年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2026-04-15-1547-1j0xemh","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2026-04-15","time":"15:47:45","subject":"公告本公司董事會通過115年股東會召開相關事宜(新增議案)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2026-04-15 15:47，「公告本公司董事會通過115年股東會召開相關事宜(新增議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2026-04-15-1502-1hkj5dk","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2026-04-15","time":"15:02:50","subject":"係因本公司有價證券於集中交易市場達公布注意交易資訊標準，故公布相關財務業務等重大訊息，以利投資人區別瞭解","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2026-04-15 15:02，「係因本公司有價證券於集中交易市場達公布注意交易資訊標準，故公布相關財務業務等重大訊息，以利投資人區別瞭解」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2026-04-15-1501-rf0iaj","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2026-04-15","time":"15:01:30","subject":"公告本公司董事會決議辦理114年度股東常會通過之第一次私募普通股定價及增資基準日等相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2026-04-15 15:01，「公告本公司董事會決議辦理114年度股東常會通過之第一次私募普通股定價及增資基準日等相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6934-2026-04-15-1436-1jhewlf","company_id":"6934","company":"心誠鎂","market":"上市","industry":"生技醫療","date":"2026-04-15","time":"14:36:07","subject":"公告本公司公司治理主管異動","clause":"第8款","fact_date":"2026-04-15","cite_as":"公開資訊觀測站重大訊息：心誠鎂（6934），2026-04-15 14:36，「公告本公司公司治理主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6934-2026-04-15-1435-p67uuk","company_id":"6934","company":"心誠鎂","market":"上市","industry":"生技醫療","date":"2026-04-15","time":"14:35:41","subject":"公告本公司內部稽核主管異動","clause":"第8款","fact_date":"2026-04-15","cite_as":"公開資訊觀測站重大訊息：心誠鎂（6934），2026-04-15 14:35，「公告本公司內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6934-2026-04-15-1435-l7qirp","company_id":"6934","company":"心誠鎂","market":"上市","industry":"生技醫療","date":"2026-04-15","time":"14:35:00","subject":"公告本公司會計主管異動","clause":"第8款","fact_date":"2026-04-15","cite_as":"公開資訊觀測站重大訊息：心誠鎂（6934），2026-04-15 14:35，「公告本公司會計主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4157-2026-04-15-1355-1vpfi49","company_id":"4157","company":"太景*-KY","market":"上櫃","industry":"生技醫療","date":"2026-04-15","time":"13:55:33","subject":"召開115年股東常會相關事宜(新增報告及討論事項)","clause":"第17款","fact_date":"2026-04-14","cite_as":"公開資訊觀測站重大訊息：太景*-KY（4157），2026-04-15 13:55，「召開115年股東常會相關事宜(新增報告及討論事項)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4195-2026-04-15-0956-1fqkmsr","company_id":"4195","company":"基米-創","market":"上市","industry":"生技醫療","date":"2026-04-15","time":"09:56:03","subject":"澄清媒體報導","clause":"第26款","fact_date":"2026-04-15","cite_as":"公開資訊觀測站重大訊息：基米-創（4195），2026-04-15 09:56，「澄清媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}